# The PROTEMBO Trial

Study · id `cardio:ct-nct05873816` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05873816](<https://clinicaltrials.gov/study/NCT05873816>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05873816

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.

## Technical summary

Registry record NCT05873816. Randomized; double masking; primary purpose prevention. Start 2024-03-21 (actual); primary completion 2025-10-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 284 participants (enrolled count; ClinicalTrials.gov record NCT05873816, source copy `cardio:ctgov-nct05873816-2026-01-09`, retrieved 2026-10-26)
- Started: 2024-03-21 (actual) (ClinicalTrials.gov record NCT05873816, source copy `cardio:ctgov-nct05873816-2026-01-09`, retrieved 2026-10-26)
- Primary completion: 2025-10-18 (actual) (ClinicalTrials.gov record NCT05873816, source copy `cardio:ctgov-nct05873816-2026-01-09`, retrieved 2026-10-26)
- Completion: 2025-12-31 (actual) (ClinicalTrials.gov record NCT05873816, source copy `cardio:ctgov-nct05873816-2026-01-09`, retrieved 2026-10-26)
- Countries: United States; Germany; Poland (ClinicalTrials.gov record NCT05873816, source copy `cardio:ctgov-nct05873816-2026-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05873816-2026-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: The PROTEMBO Trial
- Condition: Severe Aortic Valve Stenosis
- Intervention (Device): ProtEmbo - Cerebral Embolic Protection
- Intervention (Device): Sentinel - Cerebral Embolic Protection
- Lead sponsor: Protembis GmbH
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 9d8c892f3208f92565b915a1467832dfedcc72e25d2c2eb21867166bfe49cac7
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
